» Articles » PMID: 15802268

Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells is Regulated by the Phosphatidylinositol 3-kinase/PTEN/AKT/mammalian Target of Rapamycin Signaling Pathway and Activation Of...

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Apr 2
PMID 15802268
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Non-small cell lung cancer (NSCLC) expresses a particularly aggressive metastatic phenotype, and patients with this disease have a poor prognosis. CXC chemokine receptor 4 (CXCR4) is a cell surface receptor that has been shown to mediate the metastasis of many solid tumors including lung, breast, kidney, and prostate. In addition, overexpression of the epidermal growth factor receptor (EGFR) is associated with the majority of NSCLC and has been implicated in the process of malignant transformation by promoting cell proliferation, cell survival, and motility. Here we show for the first time that activation of the EGFR by EGF increases CXCR4 expression and the migratory capacity of NSCLC cells. Furthermore, many solid tumors are associated with low oxygen tension, and when NSCLC cells were cultured with EGF under hypoxic conditions, CXCR4 expression was dramatically enhanced. A molecular analysis of these events indicated that augmented CXCR4 expression was regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signal transduction pathway, activation of hypoxia inducible factor (HIF) 1alpha, and ultimately HIF-1-dependent transcription of the CXCR4 gene. Thus, a combination of low oxygen tension and overexpression of EGFR within the primary tumor of NSCLC may provide the microenvironmental signals necessary to upregulate CXCR4 expression and promote metastasis.

Citing Articles

Inflammation in cancer: therapeutic opportunities from new insights.

Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q Mol Cancer. 2025; 24(1):51.

PMID: 39994787 PMC: 11849313. DOI: 10.1186/s12943-025-02243-8.


Extracellular Regucalcin: A Potent Suppressor in the Cancer Cell Microenvironment.

Yamaguchi M Cancers (Basel). 2025; 17(2).

PMID: 39858022 PMC: 11763602. DOI: 10.3390/cancers17020240.


PTEN loss in glioma cell lines leads to increased extracellular vesicle biogenesis and PD-L1 cargo in a PI3K-dependent manner.

Sanchez J, Pierpont T, Argueta-Zamora D, Wilson K, August A, Cerione R J Biol Chem. 2024; 301(2):108143.

PMID: 39732171 PMC: 11791317. DOI: 10.1016/j.jbc.2024.108143.


The role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer.

Hou M, Yu Q, Yang L, Zhao H, Jiang P, Qin L Front Oncol. 2024; 14:1451045.

PMID: 39435279 PMC: 11491288. DOI: 10.3389/fonc.2024.1451045.


PTEN loss in glioma cell lines leads to increased extracellular vesicles biogenesis and PD-L1 cargo in a PI3K-dependent manner.

Sanchez J, Pierpont T, Argueta-Zamora D, Wilson K, August A, Cerione R bioRxiv. 2024; .

PMID: 38464280 PMC: 10925116. DOI: 10.1101/2023.07.26.550575.